TP53 and diabetes mellitus: Given that diabetes represents a state of metabolic dysregulation, it is conceivable that it induces alterations in metabolic pathways such as glycolysis and the tricarboxylic acid (TCA) cycle, which are mechanistically linked to p53 activity.